Gene Manufacturing Market
- 2026 年市場規模
- USD 9.18 Bn
- 2033 年預估規模
- USD 26.25 Bn
- 年複合成長率 CAGR
- 16.2%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
完整報告名稱與涵蓋範圍
Gene Manufacturing Market, By Product Type (Gene Therapy Vectors, Plasmid DNA, Messenger RNA (mRNA), Other Gene Manufacturing Products), By Manufacturing Process (Upstream Processing, Downstream Processing, Fill-Finish and Formulation), By Manufacturing Scale (Preclinical/Research Scale, Clinical Scale, Commercial Scale), By Application (Gene Therapy, Cell Therapy, Vaccines, Research and Other Applications), By End User (Pharmaceutical and Biotechnology Companies, Contract Development and Manufacturing Organizations (CDMOs), Academic and Research Institutions, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
The global gene manufacturing market is estimated to be valued at USD 9.18 Bn in 2026 and is expected to reach USD 26.25 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 16.2% from 2026 to 2033. The global gene manufacturing market is a disruptive sector of the biotechnology and life sciences industry that encompasses the mass production of plasmid DNA, viral vectors, mRNA and other nucleic acid-based products. The manufacturing capabilities underpin the development of gene therapy, cell therapy, CAR-T treatments and next-generation vaccines, which in turn fuels demand for scalable, high-quality and regulatory compliant production systems.
The global gene manufacturing market is driven by increasing investments in gene-based therapeutic pipelines for rare genetic conditions, cancer, and infectious diseases, which in turn increases the demand for advanced manufacturing infrastructure. It brings together biopharmaceutical companies, CDMOs, academic institutions, and government agencies, with continuous advances in genomics and bioprocessing further strengthening the demand for efficient and commercially scalable gene manufacturing technologies.
Market Dynamics
The global gene manufacturing market is driven by the rising number of gene and cell therapies progressing through clinical and commercial development and the growing need for scalable manufacturing capacity. The growth of mRNA-based technologies, government funding, public-private partnerships and collaborations in the industry are also driving investment in advanced manufacturing infrastructure.
However, a number of constraints are present in the market, such as high capital expenditure for cGMP facilities, complexity of viral-vector production, yield and batch consistency challenges and evolving regulatory requirements. Nevertheless, significant opportunities exist within the increasing outsourcing of gene manufacturing to specialized CDMOs, especially for small biopharmaceutical companies looking for flexible and cost-efficient production capabilities. Manufacturing efficiency and scalability are being improved by bioprocess automation, single-use systems, and AI-enabled quality control, while expanding gene-therapy pipelines targeting neurological, cardiovascular, and inherited metabolic disorders are driving further demand for specialized manufacturing capacity.
Key Features of the Study
• This report provides in-depth analysis of the global gene manufacturing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global gene manufacturing market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Lonza Group Ltd., Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, Catalent, Inc., Charles River Laboratories International, Inc., AGC Inc., WuXi AppTec Co., Ltd., Takara Bio Inc., and Oxford Biomedica plc
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global gene manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene manufacturing market
Market Segmentation
• Product Type Insights (Revenue, USD Bn, 2021 - 2033)
o Gene Therapy Vectors
o Plasmid DNA
o Messenger RNA (mRNA)
o Other Gene Manufacturing Products
• Manufacturing Process Insights (Revenue, USD Bn, 2021 - 2033)
o Upstream Processing
o Downstream Processing
o Fill-Finish and Formulation
• Manufacturing Scale Insights (Revenue, USD Bn, 2021 - 2033)
o Preclinical/Research Scale
o Clinical Scale
o Commercial Scale
• Application Insights (Revenue, USD Bn, 2021 - 2033)
o Gene Therapy
o Cell Therapy
o Vaccines
o Research and Other Applications
• End User Insights (Revenue, USD Bn, 2021 - 2033)
o Pharmaceutical and Biotechnology Companies
o Contract Development and Manufacturing Organizations (CDMOs)
o Academic and Research Institutions
o Others
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Lonza Group Ltd.
o Thermo Fisher Scientific Inc.
o Merck KGaA
o FUJIFILM Holdings Corporation
o Catalent, Inc.
o Charles River Laboratories International, Inc.
o AGC Inc.
o WuXi AppTec Co., Ltd.
o Takara Bio Inc.
o Oxford Biomedica plc
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Gene Manufacturing Market, By Product Type
Global Gene Manufacturing Market, By Manufacturing Process
Global Gene Manufacturing Market, By Manufacturing Scale
Global Gene Manufacturing Market, By Application
Global Gene Manufacturing Market, By End User
Global Gene Manufacturing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Type Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Industry Trends
4. Global Gene Manufacturing Market, By Product Type, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Gene Therapy Vectors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Plasmid DNA
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Messenger RNA (mRNA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Other Gene Manufacturing Products
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Gene Manufacturing Market, By Manufacturing Process, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Upstream Processing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Downstream Processing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Fill-Finish and Formulation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Gene Manufacturing Market, By Manufacturing Scale, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Preclinical/Research Scale
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Clinical Scale
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Commercial Scale
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Gene Manufacturing Market, By Application, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Gene Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Research and Other Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Gene Manufacturing Market, By End User, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Pharmaceutical and Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Contract Development and Manufacturing Organizations (CDMOs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Academic and Research Institutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Gene Manufacturing Market, By Region, 2021 - 2033, Value (USD Bn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Manufacturing Process, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Manufacturing Scale, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Manufacturing Process, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Manufacturing Scale, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Manufacturing Process, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Manufacturing Scale, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Manufacturing Process, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Manufacturing Scale, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Manufacturing Process, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Manufacturing Scale, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Manufacturing Process, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Manufacturing Scale, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
o South Africa
o North Africa
o Central Africa
10. Competitive Landscape
o Lonza Group Ltd.
Company Highlights
Product Type Portfolio
Key Developments
Financial Performance
Strategies
o Thermo Fisher Scientific Inc.
Company Highlights
Product Type Portfolio
Key Developments
Financial Performance
Strategies
o Merck KGaA
Company Highlights
Product Type Portfolio
Key Developments
Financial Performance
Strategies
o FUJIFILM Holdings Corporation
Company Highlights
Product Type Portfolio
Key Developments
Financial Performance
Strategies
o Catalent, Inc.
Company Highlights
Product Type Portfolio
Key Developments
Financial Performance
Strategies
o Charles River Laboratories International, Inc.
Company Highlights
Product Type Portfolio
Key Developments
Financial Performance
Strategies
o AGC Inc.
Company Highlights
Product Type Portfolio
Key Developments
Financial Performance
Strategies
o WuXi AppTec Co., Ltd.
Company Highlights
Product Type Portfolio
Key Developments
Financial Performance
Strategies
o Takara Bio Inc.
Company Highlights
Product Type Portfolio
Key Developments
Financial Performance
Strategies
o Oxford Biomedica plc
Company Highlights
Product Type Portfolio
Key Developments
Financial Performance
Strategies
11. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
12. References and Research Methodology
o References
o Research Methodology
o About us
Browse 32 market data tables and 28 figures on ‘Gene Manufacturing Market' - Global forecast to 2033
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們